Icon
+91 94997 68112
Login Register

Clarinex - (2.5,5 MG; Tablet, Orally Disintegrating)

Desloratadine Merck
2.5,5 MG; Tablet, Orally Disintegrating
Less Than $1000 mn
Less Than 5
Less Than 5
None None
Less Than 5
Less Than 5
Indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 6 months of age and older
Yes
*****, ** *****'* & ****** ( * ****) ***** * ****** **** ******** ******** & ***** ***** * **** ******* *** ** **** ******* ***** ***** ******* **** **** ***** ******* ********* (****) *** ****** *** ******* ** *** ****.
  1. ***, **** : *****,****** ,** ***** ***** * ****** **** ******** *** ***** ***** & ****** ***** *** ****** '*** & ** ***** ***** *** '*** & '***.
  2. ***, **** : ******** ***** * **** ******* *** *****,****** & ** ***** ** ******** ***** ** **.
  3. ***, **** : ** ***** *** ******** ******* * ********** ******* ********* ** *** ********* ***** ********* ** ********* **. *****'* *** **** *** ****** ******* ******** ** *** ********-* **- *** **-**** ******** *** ******** ******** ** ***. *, **** & *** ****** * ******* ******* ** ******** * ** ******* *** ****** *****.
  4. ***, **** : ****** *** ******** ******* * ********** ******* ********* ** *** ********* ****** **** ** ******* ** ****** * ******* ******* ** ******** ******** ********* ***. *, **** *** * ******** ***** *-**. ****** ********* **** *, ****, ********* ** ********.

Clarinex - (5 MG; Tablet)

Desloratadine Merck
5 MG; Tablet
Less Than $1000 mn
More Than 5
More Than 5
None None
More Than 5
Less Than 5
Indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 6 months of age and older
Yes
*****, ******, ******, *****, *******, ********, *********, *****, *******, ***, ****** **** *** ** ******** ****** *******. ***** ** *****'* **** ***** **** ** *** *** ************ ****. ********* (*****) ******* **** ********** **** *** *** **** (** *** ***** ** ********** ***** ********* *** ****** ******** ** **** ****).
  1. ***, **** : *****,******,******,*****, *******,********,*********,*****,*******,*** & ****** ***** * ****** **** ******** ****** *** ****** '***.
  2. ***, **** : ******** ***** * **** ******* *** *** ********* *** ***** * ****** ** *** **** ** ******** ***** ** **.
  3. ***, **** : *** ***** ** *** *** ** ******** ******** * ********* ********** ******* *******.
  4. ****, **** : ** ***** ******** ***** ***** *** ****** ****** **** ******** ******* *** ****** '***.
  5. ***, **** : ***** ***** * **** ******* ** ***** ** ******** ***** ** **.
  6. ***, **** : *** ******** ***** ***** *** **** ** ****** **** *** ******** ****** *** ****** ***.
  7. ***, **** : ***** ***** **** ******* *** ** ******** ***** ** **.
  8. ***, **** : ****** ******** ***** ***** *** **** ** ****** **** *** ******** ****** *** ****** ***.
  9. ***, **** : ***** ***** * **** ******* ****** ** ******** ***** ** **.
  10. ***, **** : ***** *** ******** ******* * ********** ******* ********* ** *** ********* ***** **** ******* *** ******** ******* **** ******** *** **** ** **** ** ****** *** ******* ******* ** **** *, ****.
  11. ***, **** : ** ***** *** ******** ******* * ********** ******* ********* ** *** ********* ***** ********* ** ********* **. *****'* *** **** *** ****** ******* ******** ** *** ********-* **- *** **-**** ******** *** ******** ******** ** ***. *, **** & *** ****** * ******* ******* ** ******** * ** ******* *** ****** ***** *** ****** ** ************* ** ********** ****.
  12. ***, **** : ***** ******** ***** ***** *** ****** ** **** *** ******** ****** *** ****** ***.
  13. ***, **** : ******** ***** **** ******* ***** ** ******** ***** ** **.
  14. *****, **** : ***** *** ******** ******* * ********** ******* ********* ** *** ********* ***** **** **** *** ***** ** ****** *** ******* ** *** *.*. ** **** *, ****, ** ******* ***** ******* *************, ** *** *.*. **** *** **** ************** ******** *** *******'* *********** *** **** ***********.
  15. ***, **** : ******** ******* * ********** ***** *** **** ** *** **** *** *****,******,*******,********,********,*** & ****** ***** *** ***** ********* **** ** ******* ** ****** * ******* ******* ** ******** ******** ********* ***. *, **** *** * ******** ***** *-**. ****** ********* **** *, ****, ********* ** ********.

Clarinex - (0.5mg/ml; Solution)

Desloratadine Merck
0.5mg/ml; Solution
Less Than $1000 mn
None None
None None
None None
Indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 6 months of age and older
Yes
*** (****) ** *** ***. ***** **** *** ** ****** *********** *** **, ****.
  1. : *** *********

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.   Privacy Policy.   Terms and Conditions.